PPBP and non-small cell lung carcinoma: We also examined the diagnostic efficacy of CTAPIII/CXCL7 in NSCLC and its diagnostic efficacy when combined with other biomarkers including CEA, SCCAg, and Cyfra211, which was recommended by National Academy of Clinical Biochemistry guidelines.